We started the process of determining a valid price forecast for Sunlink Health Systems Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Sunlink Health Systems Inc ranked in the 89th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 1864.67%. As for the metrics that stood out in our discounted cash flow analysis of Sunlink Health Systems Inc, consider:
Sunlink Health Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -152.83. This coverage rate is greater than that of merely 1.69% of stocks we're observing for the purpose of forecasting via discounted cash flows.
As a business, Sunlink Health Systems Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
SEM, HNGR, SUPN, AMS, and USNU can be thought of as valuation peers to SSY, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
SunLink Health Systems (SSY) announces the termination of its share repurchase program on June 1 per the terms of the program. A total of 87,534 shares were purchased for $100,706 prior to suspension on March 24.It also discloses that its shareholders of record have dropped below 300 to 292, entitling...
SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its share repurchase program terminated pursuant to its terms on June 1, 2020. The program was previously suspended on March 24, 2020, due to uncertainly relating to the COVID-19 pandemic.
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $46,000 (a loss of $0.01 per fully diluted share) for its third fiscal quarter ended March 31, 2020 compared to a loss of $325,000, (a loss of $0.05 per fully diluted share) for the quarter ended March 31, 2019. Net loss for the quarter ended March 31, 2020 was $158,000 (a loss of $0.02 per fully diluted share) compared to net earnings of $1,042,000 ($0.15 per fully diluted share) for the quarter ended March 31, 2019. Net earnings for the quarter ended March 31, 2019 includes a pre-tax gain of $2,136,000 on the sale of a subsidiary’s nursing home and related property.